<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39321629</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0070</ISSN><JournalIssue CitedMedium="Internet"><Volume>110</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>13</Day></PubDate></JournalIssue><Title>Diagnostic microbiology and infectious disease</Title><ISOAbbreviation>Diagn Microbiol Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Transforming respiratory tract infection diagnosis in the kingdom of saudi arabia through point-of-care testing: A white paper for policy makers.</ArticleTitle><Pagination><StartPage>116530</StartPage><MedlinePgn>116530</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.diagmicrobio.2024.116530</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0732-8893(24)00355-9</ELocationID><Abstract><AbstractText>With the evident increased prevalence of respiratory tract infections (RTIs) such as Respiratory Syncytial Virus (RSV), influenza, Group A Streptococcus (GAS), and COVID-19, the conventional diagnostic methods are considered sub-optimal in providing timely management to patients in the Kingdom of Saudi Arabia (KSA). Gaps in current diagnostics are magnified by the Kingdom's unique demographic composition, comprising 11.9 million foreign workers, and the annual influx of over 10 million pilgrims. Current gaps in timely diagnosis leads to delays in treatment, misuse of antibiotics, and protracted hospital stays, subsequently compromising patient care, and escalating healthcare costs. KSA healthcare stakeholders suggest that the integration of rapid molecular Point-of-Care Testing (POCT) into the Kingdom's healthcare infrastructure is an absolute necessity. This publication serves as an urgent call for action aimed at healthcare policymakers in Saudi Arabia, to review the existing diagnostic challenges and include rapid POCTs in the Saudi healthcare strategy for respiratory infections.</AbstractText><CopyrightInformation>Copyright Â© 2024. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Assiri</LastName><ForeName>Abdullah M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Deputyship for Preventive Health, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshahrani</LastName><ForeName>Amal M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Public Health, Ministry of Health, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakkijha</LastName><ForeName>Hussam</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlGeer</LastName><ForeName>Abdulrahman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Infection Prevention and Control, Ministry of Defense Health Services, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeitouni</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlGohary</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tawuniya Insurance, Riyadh, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhaini</LastName><ForeName>Liliane</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Consulting and Analytics, IQVIA, Dubai, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Rashi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Consulting and Analytics, IQVIA, Bengaluru, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Harmandeep</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Engagement Manager, Consulting and Analytics, IQVIA, Dubai, United Arab Emirates. Electronic address: harmandeep.singh@iqvia.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Diagn Microbiol Infect Dis</MedlineTA><NlmUniqueID>8305899</NlmUniqueID><ISSNLinking>0732-8893</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">GAS</Keyword><Keyword MajorTopicYN="N">Influenza</Keyword><Keyword MajorTopicYN="N">Point-of-care</Keyword><Keyword MajorTopicYN="N">RSV</Keyword><Keyword MajorTopicYN="N">Respiratory</Keyword></KeywordList><CoiStatement>Declaration of competing interest AM Assiri received honoraria for roundtable discussions from IQVIA. HS is the IRB chairman at King Fahad Medical City (KFMC) and a board member of the Saudi Association for Pulmonary Hypertension (SAPH). HS, LD, and RV are employees of IQVIA.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39321629</ArticleId><ArticleId IdType="doi">10.1016/j.diagmicrobio.2024.116530</ArticleId><ArticleId IdType="pii">S0732-8893(24)00355-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle>